Healthcare  Name:  Sector: Genetic Therapy Inc Healthcare  Summary: Leading developer of human gene therapy products for genetic and acquired diseases.  Stage of Initial  Investment: Venture  Liquidity: Acquired by Sandoz, which merged with CIBA Geigy to become Novartis (NYSE: NVS)
	Copyright ©2009 Rho Capital Partners, Inc.